Kite Pharma’s share price has dived after it emerged that a patient has died from cerebral oedema while being treated with its CAR-T therapy, KTE-C19. Investors were spooked by the news ...

The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an ...

Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...

Orphans and children separated from their parents in Kadugli gather to eat boiled leaves at an IDP Camp within the Sudan People's Liberation Movement-North (SPLM-N) controlled area in Boram County ...

After hours: January 31 at 6:07:32 PM EST ...

Companies that have grown profits and net profit margins over the past 12 months ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,02,211.39 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

IPC Indice de Precios Y Cotizaciones 52,050.25 494.47 0.96% ...